The Recurrent Architecture of Tumour Initiation, Progression and Drug Sensitivity

Nature Reviews Cancer - United Kingdom
doi 10.1038/nrc.2016.124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Forkhead Box Transcription Factors in Cancer Initiation, Progression and Chemotherapeutic Drug Response

Frontiers in Oncology
Cancer ResearchOncology
2014English

Parallel Progression of Tumour and Metastases

Nature Reviews Cancer
Cancer ResearchOncology
2010English

Dual-pH-Sensitivity and Tumour Targeting Core–shell Particles for Intracellular Drug Delivery

RSC Advances
ChemistryChemical Engineering
2017English

Activating Mutations and Senescence Secretome: New Insights Into HER2 Activation, Drug Sensitivity and Metastatic Progression

Breast Cancer Research
Cancer ResearchOncology
2013English

Drug Delivery: Into the Tumour

Nature
Multidisciplinary
2009English

STX140, but Not Paclitaxel, Inhibits Mammary Tumour Initiation and Progression in C3(1)/Sv40 T/T-Antigen Transgenic Mice

PLoS ONE
Multidisciplinary
2013English

Enhanced Tumour Cell Nuclear Targeting in a Tumour Progression Model

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Cancer: Bad Blood Promotes Tumour Progression

Nature
Multidisciplinary
2017English

miRNAs in Atherosclerotic Plaque Initiation, Progression, and Rupture

Trends in Molecular Medicine
Molecular MedicineMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy